Europe
Deals between five more law firms and President Trump and an antitrust lawsuit against Amgen were also among the top talking points this week
Leaders at the IP firms, which have joined forces with backing from a PE investor, share their vision of building the number one pan-European IP practice
Stefan Müller discusses managing deadlines, the importance of reflection, and why IP is more than just a 'nice to have'
The three founders of the IP firm’s new US offering say they plan to offer a unique proposition in a market fixated by the billable hour
Sponsored
Sponsored
-
Sponsored by MaiwaldEva Ehlich and Anja Fux of Maiwald summarise an EPO board ruling relating to substances and compositions in the context of medical use claims and how it could affect applicants’ portfolio strategies -
Sponsored by Gün and PartnersBarış Kalaycı and Begüm Soydan Sayılkan of Gün and Partners explain why trademark infringers have flocked to a popular part of the Turkish coast, and suggest what should be done in response
-
Sponsored by InspicosSzonja Szenczi-Molnár of Inspicos explains why patent applicants should clearly explain the alternatives and possible combinations concerning claims when drafting description text, in light of a ruling on the allowability of amendments
-
Sponsored by Bird & BirdJennifer Jones of Bird & Bird explains that there is now a rebuttable presumption of a valid priority right after a ruling by the EPO’s Enlarged Board of Appeal
-
Sponsored by Patrinos & KilimirisEvangelia Sioumala of Patrinos & Kilimiris suggests some of the reasoning applied in a decision by the Greek Trademarks Administrative Committee is not in line with settled EU case law
-
Sponsored by Gün and PartnersSelin Sinem Erciyas, Zeynep Çağla Üstün, and Beste Turan of Gün and Partners explain a decision by the Turkish Civil Court for Intellectual and Industrial Property Rights that set an important precedent for the protection of pharmaceutical patent holders’ rights
European Jurisdictions